In addition, the percentage of CD4+ cells was higher (p = 0.02, fold change = 3.15) (Fig. 5g) and percentage CD19+ cells was lower (p = 0.002, fold change = 0.45) (Fig. 5h) in tumours treated with letrozole compared to vehicle-treated tumours. Here, CD19 is linked to neoplasm.